$TGTX #Stocks #StockMarket #TgTherapeutics reported Q4 EPS on https://t.co/savSNTKlN1: Looking into results from previous quarter Sales remained unchanged from $0 millions and increased loss from $-0.69 per share. https://t.co/ov7flwawuY